Lantaca, Levi .

HRN: 23-02-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2023
CEFUROXIME 1.5GM (VIAL)
06/24/2023
06/24/2023
IV
1.5gm
Prior OR
Prophylaxis
Waiting Final Action 
06/23/2023
CEFAZOLIN 1GM (VIAL)
06/24/2023
06/24/2023
IV
2gms
Prior To OR
For TAHBSO
Waiting Final Action 
06/25/2023
CEFUROXIME 500MG (TAB)
06/25/2023
07/02/2023
PO
500
Bid
Post TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: